StockWatch
·

BAL PHARMA LTD. Q3 FY25 Results

BALPHARMAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue73.150.7%
Total Income73.660.2%
Expenditure73.091.3%
PBT0.5758.4%
Net Profit0.5250.2%
OPM-10.44%4.24pp
NPM0.70%0.72pp
EPS0.3349.2%
View full financials

Informational and educational content only. Not investment advice.